These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 27732121

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-term effects of weight-reducing drugs in people with hypertension.
    Siebenhofer A, Winterholer S, Jeitler K, Horvath K, Berghold A, Krenn C, Semlitsch T.
    Cochrane Database Syst Rev; 2021 Jan 17; 1(1):CD007654. PubMed ID: 33454957
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Drug safety evaluation of naltrexone/bupropion for the treatment of obesity.
    Verpeut JL, Bello NT.
    Expert Opin Drug Saf; 2014 Jun 17; 13(6):831-41. PubMed ID: 24766397
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Modern obesity pharmacotherapy: weighing cardiovascular risk and benefit.
    Cunningham JW, Wiviott SD.
    Clin Cardiol; 2014 Nov 17; 37(11):693-9. PubMed ID: 25223901
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity.
    Bays HE, Gadde KM.
    Drugs Today (Barc); 2011 Dec 17; 47(12):903-14. PubMed ID: 22348915
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Current and emerging pharmacotherapies for obesity in Australia.
    Hocking S, Dear A, Cowley MA.
    Obes Res Clin Pract; 2017 Dec 17; 11(5):501-521. PubMed ID: 28818558
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combination phentermine and topiramate extended release in the management of obesity.
    Alfaris N, Minnick AM, Hopkins CM, Berkowitz RI, Wadden TA.
    Expert Opin Pharmacother; 2015 Jun 17; 16(8):1263-74. PubMed ID: 25958964
    [Abstract] [Full Text] [Related]

  • 18. Naltrexone ER/Bupropion ER: A Review in Obesity Management.
    Greig SL, Keating GM.
    Drugs; 2015 Jul 17; 75(11):1269-80. PubMed ID: 26105116
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phentermine and topiramate extended-release for the obesity: new kids on the block.
    Katsi V, Marketou M, Kallistratos MS, Tousoulis D, Makris T, Manolis AJ, Vardas P, Kallikazaros I.
    Recent Pat Cardiovasc Drug Discov; 2013 Apr 17; 8(1):35-41. PubMed ID: 23565717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.